{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,8]],"date-time":"2026-01-08T11:50:24Z","timestamp":1767873024197,"version":"3.49.0"},"reference-count":26,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2006,7,18]],"date-time":"2006-07-18T00:00:00Z","timestamp":1153180800000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/2.0"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Reprod Biol Endocrinol"],"published-print":{"date-parts":[[2006,12]]},"DOI":"10.1186\/1477-7827-4-38","type":"journal-article","created":{"date-parts":[[2006,7,18]],"date-time":"2006-07-18T19:30:55Z","timestamp":1153251055000},"source":"Crossref","is-referenced-by-count":23,"title":["Recombinant versus highly-purified, urinary follicle-stimulating hormone (r-FSH vs. HP-uFSH) in ovulation induction: a prospective, randomized study with cost-minimization analysis"],"prefix":"10.1186","volume":"4","author":[{"given":"Alberto","family":"Revelli","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Francesca","family":"Poso","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Gianluca","family":"Gennarelli","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Federica","family":"Moffa","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Giuseppina","family":"Grassi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Marco","family":"Massobrio","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2006,7,18]]},"reference":[{"key":"320_CR1","doi-asserted-by":"publisher","first-page":"54","DOI":"10.1016\/S1472-6483(10)61968-2","volume":"3","author":"F Risquez","year":"2001","unstructured":"Risquez F: Induction of follicular growth and ovulation with urinary and recombinant gonadotropins. Reprod Biomed Online. 2001, 3: 54-72.","journal-title":"Reprod Biomed Online"},{"key":"320_CR2","doi-asserted-by":"crossref","first-page":"2534","DOI":"10.1093\/oxfordjournals.humrep.a135740","volume":"10","author":"HJ Out","year":"1995","unstructured":"Out HJ, Mannaerts BMJL, Driessen SGAJ, Coelingh Bennink HJT: A prospective, randomized, assessor-blind, multicentre study comparing recombinant and urinary follicle-stimulating hormone (Puregon vs Metrodin) in in-vitro fertilization. Hum Reprod. 1995, 10: 2534-2540.","journal-title":"Hum Reprod"},{"key":"320_CR3","doi-asserted-by":"publisher","first-page":"138","DOI":"10.1016\/S0015-0282(97)81490-2","volume":"68","author":"HJ Out","year":"1997","unstructured":"Out HJ, Driessen SG, Mannaerts BM, Coelingh Bennink HJ: Recombinant follicle-stimulating hormone (follitropin beta, Puregon) yields higher pregnancy rates in in vitro fertilization than urinary gonadotropins. Fertil Steril. 1997, 68: 138-142. 10.1016\/S0015-0282(97)81490-2.","journal-title":"Fertil Steril"},{"key":"320_CR4","doi-asserted-by":"publisher","first-page":"2133","DOI":"10.1093\/humrep\/12.10.2133","volume":"12","author":"C Bergh","year":"1997","unstructured":"Bergh C, Howles CM, Borg K, Hamberger L, Josefsson B, Nilsson L, Wikland M: Recombinant human follicle-stimulating hormone (r-hFSH;Gonal F) versus highly purified urinary FSH (Metrodin HP): results of a randomized comparative study in women undergoing assisted reproductive techniques. Hum Reprod. 1997, 12: 2133-2139. 10.1093\/humrep\/12.10.2133.","journal-title":"Hum Reprod"},{"key":"320_CR5","doi-asserted-by":"publisher","first-page":"332","DOI":"10.1016\/S0015-0282(00)01696-4","volume":"75","author":"E Strehler","year":"2001","unstructured":"Strehler E, Abt M, El-Danasouri I, De Santo M, Sterzik K: Impact of recombinant follicle-stimulating hormone and human menopausal gonadotropins on in vitro fertilization outcome. Fertil Steril. 2001, 75: 332-336. 10.1016\/S0015-0282(00)01696-4.","journal-title":"Fertil Steril"},{"key":"320_CR6","doi-asserted-by":"publisher","first-page":"191","DOI":"10.1023\/A:1009408029509","volume":"18","author":"JN Hugues","year":"2001","unstructured":"Hugues JN, Bry-Gauillard H, Bst\u00e4ndig B, Uzan M, Cedrin-Durnerin I: Comparison of recombinant and urinary follicle-stimulating hormone preparations in short-term gonadotropin releasing hormone agonist protocol for in vitro fertilization-embryo transfer. J Ass Reprod Genet. 2001, 18: 191-196.","journal-title":"J Ass Reprod Genet"},{"key":"320_CR7","doi-asserted-by":"publisher","first-page":"92","DOI":"10.1016\/S0015-0282(01)01684-3","volume":"75","author":"A Ravhon","year":"2001","unstructured":"Ravhon A, Lavery S, Aurell R, Trew G, Margara R, Winston R: Cilinical experience with recombinant follicle-stimulating hormone (FSH) and urinary FSH: a retrospective case-controlled analysis. Fertil Steril. 2001, 75: 92-95. 10.1016\/S0015-0282(01)01684-3.","journal-title":"Fertil Steril"},{"key":"320_CR8","doi-asserted-by":"publisher","first-page":"2207","DOI":"10.1093\/humrep\/14.9.2207","volume":"14","author":"S Daya","year":"1999","unstructured":"Daya S, Gunby J: Recombinant versus urinary follicle stimulating hormone for ovarian stimulation in assisted reproduction. Hum Reprod. 1999, 14: 2207-2215. 10.1093\/humrep\/14.9.2207.","journal-title":"Hum Reprod"},{"issue":"Suppl 1","key":"320_CR9","doi-asserted-by":"publisher","first-page":"S15","DOI":"10.1016\/S0015-0282(01)01740-X","volume":"75","author":"KM Silverberg","year":"2001","unstructured":"Silverberg KM, Ormand RA, Hansard LJ, Vaughn TC: Recombinant FSH provides more efficient, cost-effective stimulation for Ovulation Induction\/Intrauterine Insemination (OI\/IUI) cycles than higlhy purified urinary FSH. Fertil Steril. 2001, 75 (Suppl 1): S15-S16. 10.1016\/S0015-0282(01)01740-X.","journal-title":"Fertil Steril"},{"key":"320_CR10","doi-asserted-by":"publisher","first-page":"1231","DOI":"10.1093\/humrep\/15.6.1231","volume":"16","author":"R Matorras","year":"2000","unstructured":"Matorras R, Recio V, Corc\u00f3stegui B, Rodr\u00edguez-Escuedero FJ: Recombinant human FSH versus highly purified urinary FSH: a randomized study in intrauterine insemination with husbands' spermatozo. Hum Reprod. 2000, 16: 1231-1234. 10.1093\/humrep\/15.6.1231.","journal-title":"Hum Reprod"},{"key":"320_CR11","doi-asserted-by":"publisher","first-page":"19","DOI":"10.1016\/S0015-0282(97)00423-8","volume":"69","author":"HJT Coelingh Bennink","year":"1998","unstructured":"Coelingh Bennink HJT, Fauser BCJM, Out HJ: Recombinant follicle-stimulating hormone (FSH; Puregon) is more efficient than urinary FSH (Metrodin) in women with clomiphene citrate-resistant, normogonadotropic, chronic anovulation: a prospective, multicenter, assessor-blind, randomized, clinical trial. Fertil Steril. 1998, 69: 19-25. 10.1016\/S0015-0282(97)00423-8.","journal-title":"Fertil Steril"},{"key":"320_CR12","doi-asserted-by":"publisher","first-page":"276","DOI":"10.1016\/S0015-0282(99)00209-5","volume":"72","author":"H Yarali","year":"1999","unstructured":"Yarali H, Bukulmez O, Gurgan T: Urinary follicle-stimulating hormone (FSH) versus recombinant FSH in clomiphene citrate-resistant, normogonadotropic, chronic anovulation: a prospective randomized study. Fertil Steril. 1999, 72: 276-281. 10.1016\/S0015-0282(99)00209-5.","journal-title":"Fertil Steril"},{"issue":"Suppl 1","key":"320_CR13","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1093\/humrep\/11.suppl_5.95","volume":"11","author":"E Loumaye","year":"1996","unstructured":"Loumaye E, Martineau I, Piazzi A, O'Dea L, Ince S, Howles C, Decosterd G, Van Loon K, Galazka A: Clinical assessment of human gonadotrophins produced by recombinant DNA technology. Hum Reprod. 1996, 11 (Suppl 1): 95-107.","journal-title":"Hum Reprod"},{"key":"320_CR14","doi-asserted-by":"publisher","first-page":"224","DOI":"10.1159\/000050000","volume":"55","author":"AM Fulghesu","year":"2001","unstructured":"Fulghesu AM, Apa R, Belosi C, Ciampelli M, Selvaggi LJr, Cucinelli F, Caruso A, Mancuso S, Lanzone A: Recombinant versus urinary follicle-stimulating hormone in the low-dose regimen in anovulatory patients with polycystic ovary syndrome: a safer and more effective treatment. Horm Res. 2001, 55: 224-228. 10.1159\/000050000.","journal-title":"Horm Res"},{"key":"320_CR15","doi-asserted-by":"publisher","first-page":"195","DOI":"10.1016\/S1472-6483(10)62035-4","volume":"3","author":"JN Hugues","year":"2001","unstructured":"Hugues JN, Bst\u00e4ndig Bry-Gauillard B, Uzan I, C\u00e9drin-Durnerin I: Comparison of recombinant and urinary follicle stimulating hormone preparations' effectiveness for achievement of follicular selection in chronic anovulation. Reprod BioMed Online. 2001, 3: 195-198.","journal-title":"Reprod BioMed Online"},{"key":"320_CR16","first-page":"1","volume-title":"Recombinant FSH versus urinary gonadotrophins or recombinant FSH for ovulation induction in subfertility associated with polycystic ovary syndrome","author":"N Bayram","year":"2002","unstructured":"Bayram N, vanWely M, vander Veen F: Recombinant FSH versus urinary gonadotrophins or recombinant FSH for ovulation induction in subfertility associated with polycystic ovary syndrome. 2002, 1: 1-23."},{"key":"320_CR17","doi-asserted-by":"publisher","first-page":"494","DOI":"10.1016\/S1472-6483(10)61632-X","volume":"9","author":"S Gerli","year":"2004","unstructured":"Gerli S, Casini ML, Unfer V, Costabile L, Mignosa M, DiRenzo GC: Ovulation induction with urinary FSH or recombinant FSH in polycystic ovary sindrome patients: a prospective randomized analysis of cost-effectiveness. Reprod Biomed Online. 2004, 9: 494-499.","journal-title":"Reprod Biomed Online"},{"key":"320_CR18","doi-asserted-by":"publisher","first-page":"573","DOI":"10.1016\/j.fertnstert.2004.04.026","volume":"82","author":"S Gerli","year":"2004","unstructured":"Gerli S, Casini ML, Unfer V, Costabile L, Bini V, Di Renzo GC: Recombinant versus urinary follicle-stimulating hormone in intrauterine insemination cycles: a prospective, randomized analysis of cost effectiveness. Fertil Steril. 2004, 82: 573-578. 10.1016\/j.fertnstert.2004.04.026.","journal-title":"Fertil Steril"},{"key":"320_CR19","volume-title":"WHO Laboratory Manual for the Examination of Human Semen-Cervical Mucus Interaction","author":"World Health Organization","year":"1992","unstructured":"World Health Organization: WHO Laboratory Manual for the Examination of Human Semen-Cervical Mucus Interaction. 1992, Cambridge University Press, Cambridge, UK"},{"key":"320_CR20","doi-asserted-by":"publisher","first-page":"172","DOI":"10.1093\/humupd\/2.2.172","volume":"2","author":"CM Howles","year":"1996","unstructured":"Howles CM: Genetic engineering of human FSH (Gonal F). Hum Reprod Update. 1996, 2: 172-191. 10.1093\/humupd\/2.2.172.","journal-title":"Hum Reprod Update"},{"key":"320_CR21","doi-asserted-by":"publisher","first-page":"1671","DOI":"10.1093\/humrep\/17.6.1671-b","volume":"17","author":"H Al-Inany","year":"2002","unstructured":"Al-Inany H, Afnan M: Models of cost-effectiveness of recombinant FSH versus urinary FSH. Hum Reprod. 2002, 17: 1671-1674. 10.1093\/humrep\/17.6.1671-a.","journal-title":"Hum Reprod"},{"key":"320_CR22","doi-asserted-by":"publisher","first-page":"520","DOI":"10.1093\/humrep\/15.3.520","volume":"15","author":"R Frydman","year":"2000","unstructured":"Frydman R, Howles CM, Truong F: A double-blind, randomized study to compare recombinant human follicle stimulating hormone (FSH; Gonal-F\u00ae) with highly purified urinary FSH (Metrodin\u00ae HP) in women undergoing assisted reproductive techniques including intracytoplasmic sperm injection. Hum Reprod. 2000, 15: 520-525. 10.1093\/humrep\/15.3.520.","journal-title":"Hum Reprod"},{"key":"320_CR23","doi-asserted-by":"publisher","first-page":"1691","DOI":"10.1093\/humrep\/15.8.1691","volume":"15","author":"R Schats","year":"2000","unstructured":"Schats R, De Sutter P, Bassil S, Kremer JAM, Tournaye H, Donnez J: Ovarian stimulation during assisted reproduction treatment: a comparison of recombinant and highly purified urinary human FSH. Hum Reprod. 2000, 15: 1691-1697. 10.1093\/humrep\/15.8.1691.","journal-title":"Hum Reprod"},{"key":"320_CR24","doi-asserted-by":"publisher","first-page":"371","DOI":"10.1093\/molehr\/2.5.371","volume":"5","author":"W Olijve","year":"1996","unstructured":"Olijve W, de Boer W, Mulders JWM, van Wezenbeeck PM: Molecular biology and biochemistry of human recombinant stimulating hormone (Puregon). Mol Hum Reprod. 1996, 5: 371-382.","journal-title":"Mol Hum Reprod"},{"key":"320_CR25","doi-asserted-by":"publisher","first-page":"552","DOI":"10.1023\/A:1022586221077","volume":"15","author":"J Balasch","year":"1998","unstructured":"Balasch J, Fabregues F, Pennarrubia J, Creus M, Vidal R, Casamitjana I, Manau D, Vanrell JA: Follicular development and hormonal levels following highly purified or recombinant follicle stimulating hormone administration in ovulatory women and WHO group II anovulatory infertile patients. J Ass Reprod Genet. 1998, 15: 552-559. 10.1023\/A:1022586221077.","journal-title":"J Ass Reprod Genet"},{"key":"320_CR26","doi-asserted-by":"publisher","first-page":"2563","DOI":"10.1093\/humrep\/16.12.2563","volume":"16","author":"S Daya","year":"2001","unstructured":"Daya S, Ledger W, Auray JP, Duru G, Silverberg K, Wikland M, Bouzayen R, Howles CM, Beresniak A: Cost-effectiveness modelling of recombinant FSH versus urinary FSH in assisted reproduction techniques in the UK. Hum Reprod. 2001, 16: 2563-2569. 10.1093\/humrep\/16.12.2563.","journal-title":"Hum Reprod"}],"container-title":["Reproductive Biology and Endocrinology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/1477-7827-4-38.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1186\/1477-7827-4-38\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/1477-7827-4-38.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,1,22]],"date-time":"2019-01-22T22:27:07Z","timestamp":1548196027000},"score":1,"resource":{"primary":{"URL":"https:\/\/rbej.biomedcentral.com\/articles\/10.1186\/1477-7827-4-38"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2006,7,18]]},"references-count":26,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2006,12]]}},"alternative-id":["320"],"URL":"https:\/\/doi.org\/10.1186\/1477-7827-4-38","relation":{},"ISSN":["1477-7827"],"issn-type":[{"value":"1477-7827","type":"electronic"}],"subject":[],"published":{"date-parts":[[2006,7,18]]},"article-number":"38"}}